Stocks · News reference
BTIG analyst Jeet Mukherjee reiterates Ascentage Pharma Group (NASDAQ:AAPG) with a Buy and maintains $48 price target.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
U.S. stock futures fell; Constellation Brands dropped 5.1% despite beating estimates, while biotech, mining and other stocks declined premarket.
U.S. stock futures fell as HubSpot dropped after a downgrade; Roze AI, UMC, Quantum-Si, Intel and others also declined premarket.
U.S. stock futures rose, while Nike plunged 9.5% after missing revenue estimates. Roze AI, Mangoceuticals and other stocks also fell premarket.